Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Moving up for some reason. Last trade .32
Almost a million so far. Life is wonderful!
Tough resistance at 0.0725. No real big bids or asks all day, but some nice size trades. More of a standoff, but I would have expected 0.0725 to breakout considering the volume we had.
Tough resistance at the 0.0725 area. Blowing through should go to a dime.
Solid volume today.
Seems somewhat positive with the warrants priced at 0.16. Must be looking to a positive future.
News out. Private placement:
Volt Carbon Technologies Announces $960,000 Private Placement
March 6, 2023, Calgary, Alberta, Canada – Volt Carbon Technologies Inc. (“Volt Carbon” or the “Company”) (TSX-V: VCT) (OTCQB: TORVF) is pleased to announce that it intends to complete a non-brokered private placement financing of up to 12,000,000 Units (the “Units”) at a price of $0.08 per Unit for gross proceeds of up to $960,000 (the “Offering”).
Each Unit will consist of one (1) common share in the capital of the Company and one (1) common share purchase warrant (each a “Warrant”). Each Warrant will entitle the holder to acquire one (1) additional common share in the capital of the Company (each a “Warrant Share”) at an exercise price of $0.16 per Warrant Share for a period of 24 months from the date of issuance. All common shares issued under the Offering will be subject to a four-month plus one day hold period.
In connection with the Offering, the Company may pay a cash finder’s fee to certain eligible finders (collectively, the “Finders”) equal to 8% of the aggregate gross proceeds received by the Company from purchasers of Units sourced by the Finders.
The Company intends to use the proceeds of the Offering to pay outstanding payables, purchase additional equipment to advance battery and mineral separation technology, evaluate and potentially option additional mineral claims and for working capital. Although the Company intends to use the proceeds of the Offering as described above, the actual allocation of net proceeds may vary from the uses set forth above, depending on future operations or unforeseen events or opportunities.
Closing of the Placement is subject to customary conditions and regulatory approvals including the approval of the TSX Venture Exchange. The Company anticipates closing the Offering on or about March 31, 2023.
About Volt Carbon Technologies
Volt Carbon is a publicly traded carbon science company, with specific interests in energy storage and green energy creation, with holdings in mining claims in the provinces of Ontario, Quebec and British Columbia in Canada. For the latest information on Volt Carbon’s properties and news please refer to the website www.voltcarbontech.com.
On behalf of the Board of Directors,
Volt Carbon Technologies Inc.
V-Bond Lee, P. Eng.
CEO, President, Chairman of the Board and Director
I think the rabbit testing results are further along than we think.
I'll take the igloo for $100.
Break through .0725 could easily take us to a dime.
Over a million traded so far. Life is great.
Good. The more I can add down here.
And who said that the MAYO Clinic wasn't talking with the FDA? Coincidence.....highly doubtful.
Number 6 on the breakout boards. Hope the doctor PR's the update....we would go to number 1 in a heart beat.
Or higher by the end of the week.
Have to wonder if the doctor will PR the update on the wires before the market opens tomorrow?
34 on the breakout boards and moving up fast.
Sleep tight if you can!!
February 28, 2023
Vivos February 2023 Update | IsoPet® - RadioGel™
• VX-2 Animal Study Initiated | Draft IDE Submission to the FDA
VX-2 Animal Study Initiated
After several months of planning, preparation, and FDA review the first VX-2 tumors were injected with low-activity IsoPet® to deliver a very high 800 Gy dose. The local activity is now being measured over time using PET-CT to demonstrate that the IsoPet® will kill the VX-2 tumors and that the hydrogel effectively keeps the Yttrium-90 at the point of injection, thus limiting the migration to other areas of the body.
Just prior to this injection a full-dress rehearsal into surrogate tissue was conducted to demonstrate the refined precision techniques using our new Injection Guidance and Activity Tracking Table and our newly patented Peltier Chiller and ancillary equipment. This precision is required when injecting < 0.2 cc into a 1 cc tumor based on the calculated recommendation from our guidance table. This exact technique will be used by Mayo Clinic to eventually treat cancerous lymph nodes. Mayo is scheduled to conduct its own surrogate tissue training exercise in April.
We have now demonstrated that our standardized procedures and support equipment can be used to treat tumors ranging from these small sizes to very large (up to a pound) equine tumors.
Draft IDE Submitted to the FDA
All the pre-clinical testing is completed, except for the VX-2/rabbit study, so we submitted a draft IDE. It is prudent to obtain continuous FDA feedback to expedite the final submittal. It is anticipated that the FDA comments will be received in early April. After the animal study is completed the final draft of the IDE will be submitted.
"This exact technique will be used by Mayo Clinic to eventually treat cancerous lymph nodes. Mayo is scheduled to conduct its own surrogate tissue training exercise in April."
Mike Korenko, Sc.D • CEO • President
The Effort to Qualify Additional Vendors for our Key Product Components
As reported earlier this month, evolving away from single-source production of the primary components of IsoPet/RadioGel is a strategic objective.
Last year we developed two alternate suppliers for the polymer that is used to produce the hydrogel component. This year we are focusing on locating a second supplier for our yttrium phosphate particles.
This month an Eckert & Ziegler representative observed a full production run at IsoTherapeutics, our current component supplier, to create a solid basis for future meaningful discussions.
Thank you for your continued support.
Mike Korenko, Sc. D
CEO & President Vivos, Inc.
Possible timelines....April....only 2 months away.
Ask just got real thin to outer space.
Fine with me....except I am still to get a few more below .06.
One would think that we would have a little more volume going into an update this week. Maybe this afternoon.
Wait till she turns six!!
I give the good doctor credit in getting out the monthly updates consistently and on time. Now...let's start to move up consistently!!
If you are respectful, he answers.
Put in a buy order at 0.057 and Etrade filled at 0.056.
Closing in on a million share day in volume.
Very doubtful that is the case. Volume would be a lot higher.
Volume coming in fast.
Got some at 0.0541.
Added a few more at 0.06.
What's happening tomorrow?
News is out:
Volt Carbon Technologies Announces the Appointment of a new CFO and Grants Options to a Director and Employees
February 15, 2023, Calgary, Alberta, Canada – Volt Carbon Technologies Inc. (“Volt Carbon” or the “Company”) (TSX-V: VCT) (OTCQB: TORVF) is pleased to announce the appointment of Carmelo Marrelli as Chief Financial Officer of the Company effective March 1st 2023, subject to approval by the TSX Venture Exchange (“TSX-V”).
Mr. Marrelli brings more than 20 years of financial reporting experience and brings significant experience and support to the Company. Mr. Marrelli is a Chartered Professional Accountant (CPA, CA, CGA), and a member of the Institute of Chartered Secretaries and Administrators, a professional body that certifies corporate secretaries. He received a Bachelor of Commerce degree from the University of Toronto. Mr. Marrelli is the principal of the Marrelli Group, an organization which has provided accounting, corporate secretarial and regulatory compliance services to listed companies on various exchanges for over twenty years. Mr. Marrelli acts as the Chief Financial Officer to several other issuers listed on the TSX, TSX-V and CSE, as well as non-listed companies, and serves as a director of certain issuers.
The company wishes to thank Dr David Madill for his role as Interim CFO.
Pursuant to the Company’s stock option plan, Volt Carbon announces that it has granted an aggregate of 1,500,000 options to a current Director of the Company with an exercise price of $0.12. Additionally, an aggregate of 350,000 options have been granted to current employees and consultants of the Company at an exercise price of $0.08. All options granted expire on February 28, 2028.
About Volt Carbon Technologies
Volt Carbon is a publicly traded carbon science company, with specific interests in energy storage and green energy creation, with holdings in mining claims in the provinces of Ontario, Quebec and British Columbia in Canada. For the latest information on Volt Carbon’s properties and news please refer to the website www.voltcarbontech.com.
On behalf of the Board of Directors,
Volt Carbon Technologies Inc.
V-Bond Lee, P. Eng.
CEO, President, Chairman of the Board and Director
I agree 100%.
But they stated it (10K) will/might be late. Not a problem though as the annual 10K will be audited.
Not attracting very many flies.
Going with Nellie Fox and Luis Aparicio.....
Oh OSCAR. Come out wherever you a are!!